CHELONI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 827
NA - Nord America 743
AS - Asia 107
Totale 1.677
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 740
PL - Polonia 570
IT - Italia 99
IE - Irlanda 65
CN - Cina 35
SE - Svezia 35
HK - Hong Kong 30
JO - Giordania 16
RU - Federazione Russa 14
VN - Vietnam 12
SG - Singapore 10
DE - Germania 8
FI - Finlandia 8
GB - Regno Unito 8
BE - Belgio 7
AT - Austria 5
CA - Canada 3
FR - Francia 3
ID - Indonesia 3
CH - Svizzera 2
NL - Olanda 2
IN - India 1
UA - Ucraina 1
Totale 1.677
Salva come PNG Salva come JPEG
Città #
Warsaw 570
Fairfield 103
Chandler 83
Dublin 65
Seattle 64
Ashburn 56
Woodbridge 52
Houston 44
Ann Arbor 39
Cambridge 37
Wilmington 33
Florence 29
Altamura 18
Beijing 18
Hong Kong 18
Lawrence 17
Princeton 17
Buffalo 11
Boston 10
Dong Ket 10
San Diego 9
Kent 8
Brussels 7
Moscow 7
Shanghai 7
Boardman 6
Falls Church 6
Redwood City 6
Rome 6
Turin 6
Renton 5
Vienna 5
Cagliari 4
Medford 4
Phoenix 4
Singapore 4
Detroit 3
Malang 3
Geneva 2
Jacksonville 2
Karlskrona 2
London 2
Munich 2
Norwalk 2
Rubano 2
Toronto 2
Trumbull 2
Austin 1
Baotou 1
Brookline 1
Cantagallo 1
Carrara 1
Castel Volturno 1
Castelliri 1
Contursi 1
Costa Mesa 1
Cuneo 1
Gallatin 1
Guangzhou 1
Gunzenhausen 1
Laurel 1
Ottawa 1
Parma 1
Pune 1
Redmond 1
Rotterdam 1
Scandicci 1
Stevenage 1
Totale 1.433
Salva come PNG Salva come JPEG
Nome #
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 246
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 236
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction 236
Chronic myeloid leukaemia stem cells are sensitive to the pharmacological inhibition of hypoxia inducible factor-1a 229
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 182
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 100
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 91
Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival 85
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 71
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 55
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS 47
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 47
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 45
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 40
Totale 1.710
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020401 22 46 20 28 51 40 36 49 39 29 35 6
2020/2021263 18 41 3 39 19 24 12 20 26 38 9 14
2021/2022132 9 10 10 7 9 8 3 10 5 15 20 26
2022/2023322 29 53 21 13 32 49 41 24 48 2 7 3
2023/2024123 7 9 12 9 6 11 10 30 3 4 16 6
2024/202523 23 0 0 0 0 0 0 0 0 0 0 0
Totale 1.710